SkylineDx retweeted
🗞️ Press news: Biocartis Initiates Commercialization in Europe of @SkylineDx 's Innovative #Merlin™ Assay (CE-IVD) for #Melanoma Patients. More info on investors.biocartis.com/en/p… bit.ly/3e9t4F1
SkylineDx retweeted
🙌Soon available!
The Merlin™ Test, developed by our partner @skylinedx BV, which helps identify #melanoma patients who may safely forgo the sentinel lymph node biopsy (SLNB)! ♥️
lnkd.in/ei-PfQud
@Melanoma_doctor @MelanomaNetwork @melanoma_fund @theNCI @UmbertoMalapel1
SkylineDx retweeted
🗞️ Press news: Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner @SkylineDx at EADO2022 Conference 🇪🇸
More info on investors.biocartis.com/en/p…
SkylineDx retweeted
Today is #WorldCancerDay! Explore how people living with cancer can be empowered thanks to #MedicalTechnologies
📽️Watch our series #ConnectingTheDots: bit.ly/3vpTO7t
SkylineDx retweeted
Thanks to #DigitalHealth, simple diagnostic tests can enable delivery of more targeted treatments & empower #myeloma patients to take an active role in their recovery #ConnectingTheDots #NCDs
📽️Learn more: bit.ly/2ZUrcce
SkylineDx retweeted
#Acquisitions & Partnerships :
~@pfizer acquires #AmplyxPharmaceuticals
~@Tridiuum & #NOCD partner on #OCD diagnosis
~@ButterflyNetInc $BFLY partners w/ @SientraInc $SIEN breast implant #ultrasound
~@skylinedx & @Biocartis_ partner to develop #melanoma risk test
SkylineDx retweeted
New validation data on the Merlin test for #melanoma risk assessment by @WVUMedicine, @MayoClinic, @MayoClinicCIM and @SkylineDx: lnkd.in/gXmqZgg
SkylineDx retweeted
👌
Yesterday on @KanaalZCanalZ : a video #news item on the partnership agreement between @skylinedx & @Biocartis_ [in Dutch]
#diagnosticsispower
#playtogethertowin
#melanoma
kanaalz.knack.be/nieuws/bioc…
SkylineDx retweeted
Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test
@Biocartis_ @skylinedx
bit.ly/32EA4kc
SkylineDx retweeted
Strong @Biocartis_ results this morning, 70% cartridge vol growth vs non-COVID19 impacted 1Q20. Impressive considering 68% growth in 1Q20. Novel partnership in melanoma with @skylinedx to top it off. $BCART
SkylineDx retweeted
📰 Press news: Biocartis and @SkylineDx Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idylla™ 🤩 #NewAssay #HighValue #Rapid #Easy #Diagnostics #Melanoma 👉 investors.biocartis.com/en/p…
SkylineDx retweeted
Biocartis & SkylineDx Sign Collaboration to Develop Test Predicting Risk for Nodal Metastasis in Melanoma, on Idylla globenewswire.com/news-relea… @Biocartis_ @skylinedx More Benelux life science business news at [LSBNL] at life-sciences-benelux.com/ne…
SkylineDx retweeted
👉🛎️ Press news: Biocartis and @skylinedx 🇳🇱 🇺🇸 Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idylla™ 😍 investors.biocartis.com/en/p…
SkylineDx retweeted
📰 Press news: Biocartis and @SkylineDx Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idylla™ 🤩 #NewAssay #HighValue #Rapid #Easy #Diagnostics #Melanoma 👉 investors.biocartis.com/en/p…
SkylineDx retweeted
World Congress of Melanoma 2021: Check out the satellite symposium "Refining the role of SLNB?" concerning SNB and melanoma. Excellent work by Tina Hieken @TJH0828 Sponsored by @skylinedx
vimeo.com/537616393/1882533b…
SkylineDx retweeted
This is another utility of the CP-GEP test. In a very fruitful collaboration between @ErasmusMC and @SahlgrenskaAcad we show that the Merlin assay @skylinedx adds extra prognostic information in patients with stage II #melanoma
SkylineDx retweeted
Validation of @axm27 @MayoClinic C-GEP model by @OlofssonBagge @skylinedx on 10th World Congress of Melanoma & 17th EADO Congress 2021 xitter.cf/skylinedx/status/13819… via @walls_io #melanoma #EADO2021
1/3 - Poster presentation at #10thWCM #eado2021 #10thworldcongressofmelanoma
See poster below for more details 👇 high-res poster via this link: falconprogram.com/files/post…
#diagnosticsispower
SkylineDx retweeted
For those with an interest in high-risk #myeloma - our 'story behind the paper' on #MyelomaXI combined molecular risk profiling. Another great #UKMRA collaboration @profghjackson
@CTRUmyeloma @profBigG
go.nature.com/2XNlyDV
SkylineDx retweeted
Skin cancer test by @axm27 at @MayoClinic and @skylinedx! Another great step towards implementing research results in clinical practice!
skylinedx.com/news/skin-canc…
ascopubs.org/doi/full/10.120…


























